Fundz

Evergreen Theragnostics Completes $15M Series B, Launches Discovery Unit, And Prepares Ga-68 Dotatoc Supply Chain

RECENTLY ACQUIREDMar 13, 2023

Amount Raised

$15 Million

Round Type

Series B

SummitManufacturingBiotechnologyHealth CareMedical Device

Description

Evergreen Theragnostics, a clinical stage contract development and manufacturing organization (CDMO) developing radiopharmaceuticals for cancer therapy, today announced the completion of a $15M Series B capital raise. The round was primarily subscribed by existing shareholders exercising their rights of first refusal.

Quick answer

Evergreen Theragnostics raised $15 Million in a Series B round, dated March 13, 2023. Evergreen Theragnostics is based in Summit, Ohio, United States.

How much did Evergreen Theragnostics raise?
Evergreen Theragnostics raised $15 Million in a Series B round on March 13, 2023.
What does Evergreen Theragnostics do?
Evergreen Theragnostics is focused on improving the available options for cancer patients using radiopharmaceuticals.
Where is Evergreen Theragnostics based and how big is it?
Evergreen Theragnostics is based in Summit, Ohio, United States.
Who are the decision-makers at Evergreen Theragnostics?
Fundz holds 1 contact at Evergreen Theragnostics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical Device and Manufacturing around the same time

Companies in the same sectors as Evergreen Theragnostics that raised within 45 days of this round, from Fundz verified event records.

  • Shape Memory Medical raised $4.8M (Seed) on April 24, 2023.
  • MedShift raised $108M (Funding Round) on April 20, 2023.
  • Amend Surgical raised an undisclosed amount (Funding Round) on April 11, 2023.
  • Harvard Apparatus Regenerative Technology raised $6M on March 31, 2023.
  • Flyte Aviation, Inc. raised $8M on March 23, 2023.
  • NuVision Biotherapies raised $1.3M (Seed) on March 9, 2023.

Who to call at Evergreen Theragnostics, and when

A new round usually means Evergreen Theragnostics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Evergreen Theragnostics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Evergreen Theragnostics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Evergreen Theragnostics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Evergreen Theragnostics

Location

Summit, Ohio, United States

About

Evergreen Theragnostics is focused on improving the available options for cancer patients using radiopharmaceuticals. The company is engaged in three core areas: CDMO, Products, and Drug Discovery. Evergreen is headquartered in Springfield, NJ in a state-of-the-art GMP radiopharmaceutical facility. The company was founded in 2019 by a team that brings a strong track record in theragnostic radiopharmaceutical manufacturing and commercialization. For more information, please visit www.evergreentgn.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Evergreen Theragnostics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Evergreen Theragnostics's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

Evergreen Theragnostics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.